Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra M Quezada

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Digestive Diseases and Sciences|December 4, 2019
Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-EfficacyZaid Bilgrami, Ameer Abutaleb, Kenechukwu Chudy-Onwugaje, et al.
Inflammatory Bowel Diseases|May 23, 2018
Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 YearAmeer Abutaleb, Andrea Buchwald, Kenechukwu Chudy-Onwugaje, et al.
The American Journal of Gastroenterology|November 10, 2018
A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD)Raymond K Cross, Patricia Langenberg, Miguel Regueiro, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Digestive Diseases and Sciences|December 4, 2019
Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-EfficacyZaid Bilgrami, Ameer Abutaleb, Kenechukwu Chudy-Onwugaje, et al.
Inflammatory Bowel Diseases|May 23, 2018
Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 YearAmeer Abutaleb, Andrea Buchwald, Kenechukwu Chudy-Onwugaje, et al.
The American Journal of Gastroenterology|November 10, 2018
A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD)Raymond K Cross, Patricia Langenberg, Miguel Regueiro, et al.
Pageof 3